MarkUrbanRarickMD

PubMed

• A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metast...
  O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler AL, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Boles J, Nazem...> ;Ann. Oncol.. 2016-06-01
• A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metast...
  O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Leichman L, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler L, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Bol...> ;Ann. Oncol.. 2015-12-01
• 133 citations
  Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer
  Mitesh J. Borad, Shantan G. Reddy, Nathan Bahary, Hope E. Uronis, Darren Sigal, Allen Lee Cohn, William R. Schelman, Joe Stephenson, E. Gabriela Chiorean, Peter Rosen,...> ;Journal of Clinical Oncology. 2015 May 1
• 112 citations
  A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small cell lung cancer
  Alberto Chiappori, Tatjana Kolevska, David R. Spigel, Steven Hager, Mark U. Rarick, S. Gadgeel, Normand Blais, J. von Pawel, Lowell L. Hart, Martin Reck, Ekaterina Bas...> ;Annals of Oncology. 2015 Feb 1
• 24 citations
  Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer
  Brian M. Wolpin, Eileen M. O'Reilly, Yoo-Joung Ko, Lawrence S. Blaszkowsky, M. U. Rarick, Caio Rocha-Lima, Paul S. Ritch, Emily Chan, Jennifer L. Spratlin, Teresa Maca...> ;Annals of Oncology. 2013 Jul 1
• 34 citations
  A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome
  Azra Raza, Naomi Galili, Scott E. Smith, John E. Godwin, Ralph V. Boccia, Han Myint, Daruka Mahadevan, Deborah Mulford, Mark U. Rarick, Gail L. Brown, Dale G. Schaar, ...> ;Cancer. 2012 Apr 15
• Randomized phase II study of the efficacy and safety of gemcitabine plus TH-302 versus gemcitabine alone in previously untreated patients with advanced pancreatic cancer.
  Borad MJ, Sigal D, Uronis H, Stephenson J, Bahary N, Rarick MU, DeMarco LC, Finnegan TJ, Chiorean EG, Ryan DP, Cohn AL, Ulrich BK, Harish VC, Anderes EN, Ma WW, Yu PP,...> ;J. Clin. Oncol.. 2011-05-20
• Global, multicenter, open-label, randomized phase II trial comparing gemcitabine (G) with. G plus AGS-1C4D4 (A) in patients (pts) with metastatic pancreatic cancer (mPC).
  Wolpin BM, O'Reilly EM, Ko Y, Blaszkowsky LS, Rarick MU, Rocha Lima CMS, Ritch PS, Chan E, Spratlin JL, Macarulla T, McWhirter E, Pezet D, Lichinitser M, Roman LD, Har...> ;J. Clin. Oncol.. 2011-05-20
• 234 citations
  Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update
  J. Douglas Rizzo, Mark R. Somerfield, Karen L. Hagerty, Jerome Seidenfeld, Julia Bohlius, David Cella, Benjamin Djulbegovic, Matthew J. Goode, Ann A. Jakubowski, Mark ...> ;Journal of Clinical Oncology. 2008 Jan 1
• 125 citations
  Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update.
  J. Douglas Rizzo, Mark R. Somerfield, Karen L. Hagerty, Jerome Seidenfeld, Julia Bohlius, David Cella, Benjamin Djulbegovic, Matthew J. Goode, Ann A. Jakubowski, Mark ...> ;Blood. 2008 Jan 1
• 38 citations
  Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel
  Tomasz M. Beer, Celestia S. Higano, Mansoor N. Saleh, Robert Dreicer, Gary R. Hudes, Joel Picus, Mark U. Rarick, Louis Fehrenbacher, Alison L. Hannah> ;Investigational New Drugs. 2007 Jul 7
• 27 citations
  A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma.
  Helen J. Ross, Lowell L. Hart, Paul Swanson, Mark U. Rarick, Robert A. Figlin, Andrew D. Jacobs, David E. McCune, Arthur H. Rosenberg, Ari D. Baron, Laurie E. Grove, M...> ;Lung Cancer. 2006 Oct 1
• Randomized phase II study of SGN-15 (CBR96-doxorubicin immunoconjugate) with docetaxel in patients with advanced or metastatic non-small cell lung cancer (NSCLC).
  Ross HJ, Rudin CM, Hart LL, Swanson PM, Rarick MU, Figlin RA, Jacobs AD, Miller DM> ;J. Clin. Oncol.. 2004-07-15
• 273 citations
  Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of Hematology
  J. Douglas Rizzo, Alan E. Lichtin, Steven H. Woolf, Jerome Seidenfeld, David Cella, Benjamin Djulbegovic, Matthew J. Goode, Ann A. Jakubowski, Stephanie J. Lee, Carole...> ;Journal of Clinical Oncology. 2002 Oct 1
• 179 citations
  Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.
  J. Douglas Rizzo, Alan E. Lichtin, Steven H. Woolf, Jerome Seidenfeld, David Cella, Benjamin Djulbegovic, Matthew J. Goode, Ann A. Jakubowski, Stephanie J. Lee, Carole...> ;Blood. 2002 Oct 1
• 18 citations
  Treatment of a unique anemia in patients with IDDM with epoetin alfa.
  Mark U. Rarick, Byron M. Espina, Daniel T Colley, Aaron Chrusoskie, Shannan Gandara, Donald I. Feinstein> ;Diabetes Care. 1998 Mar 1
• 279 citations
  Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
  Parkash S. Gill, J C Wernz, David T. Scadden, P Cohen, G M Mukwaya, J H Von Roenn, M Jacobs, S Kempin, I Silverberg, G Gonzales, Mark U. Rarick, A M Myers, F Shepherd,...> ;Journal of Clinical Oncology. 1996 Aug 1
• 11 citations
  The use of fine needle aspiration cytology in the management of human immunodeficiency virus-related non-Hodgkin's lymphoma and Hodgkin's disease.
  Strigle Sm, Martin Se, Alexandra M. Levine, Mark U. Rarick> ;Journal of Acquired Immune Deficiency Syndromes. 1993 Dec 1
• 2 citations
  Human immunodeficiency virus-related lymphoma: prognostic factors predictive of survival.
  B Taillan, G Garnier, S Schneider, A Pesce, J G Fuzibet, P Dujardin> ;Cancer. 1993 May 1
• 30 citations
  Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma.
  Christine Walsh, J C Wernz, Alexandra M. Levine, Mark U. Rarick, E Willson, D Melendez, E Bonnem, J Thompson, B Shelton> ;Journal of Acquired Immune Deficiency Syndromes. 1993 Mar 1
• 27 citations
  Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma.
  Parkash S. Gill, Marjorie Bernstein-Singer, Byron M. Espina, Mark U. Rarick, Florence Magy, T Montgomery, Matthew S. Berry, Alexandra M. Levine> ;AIDS. 1992 Dec 1
• 44 citations
  Thrombotic thrombocytopenic purpura in patients with human immunodeficiency virus infection: a report of three cases and review of the literature.
  Mark U. Rarick, Byron M. Espina, R. Mocharnuk, Yvonne Trilling, Alexandra M. Levine> ;American Journal of Hematology. 1992 Jun 1
• 15 citations
  A review of the fine-needle aspiration cytology findings in human immunodeficiency virus infection.
  Stephen M. Strigle, Mark U. Rarick, Michele M. Cosgrove, Sue Ellen Martin> ;Diagnostic Cytopathology. 1992 Jan 1
• 5 citations
  Intravenous immune globulin use in patients with human immunodeficiency virus-related thrombocytopenia who require dental extraction.
  Mark U. Rarick, P Burian, N de Guzman, Byron M. Espina, T Montgomery, D Jamin, A M Levine> ;The Western Journal of Medicine. 1991 Dec 1
• Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival.
  Levine AM, Sullivan-Halley J, Pike MC, Rarick MU, Loureiro C, Bernstein-Singer M, Willson E, Brynes R, Parker J, Rasheed S> ;Cancer. 1991-12-01
• Join now to see all